These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22862994)

  • 1. Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions.
    Rutherford ME; Hill PC; Triasih R; Sinfield R; van Crevel R; Graham SM
    Trop Med Int Health; 2012 Oct; 17(10):1264-73. PubMed ID: 22862994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid preventive therapy programmes for healthcare workers in India: translating evidence into policy.
    Raj R; Prasad H; Arya BK; Bhattacharya SD
    Natl Med J India; 2011; 24(4):201-7. PubMed ID: 22208138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tuberculin screening and isoniazid preventive therapy program in an inner-city population.
    Bock NN; Metzger BS; Tapia JR; Blumberg HM
    Am J Respir Crit Care Med; 1999 Jan; 159(1):295-300. PubMed ID: 9872853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of the symptom-based screening approach to the management of children who are contacts of tuberculosis cases.
    Triasih R; Robertson CF; Duke T; Graham SM
    Clin Infect Dis; 2015 Jan; 60(1):12-8. PubMed ID: 25270649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases.
    Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.
    Teklay G; Teklu T; Legesse B; Tedla K; Klinkenberg E
    BMC Public Health; 2016 Aug; 16(1):840. PubMed ID: 27543096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework.
    Sadatsafavi M; Marra C; Marra F; Moran O; FitzGerald JM; Lynd L
    Value Health; 2013; 16(1):66-75. PubMed ID: 23337217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement.
    Nelson LJ; Jereb JA; Castro KG
    Pediatrics; 2004 Oct; 114(4):1084-6. PubMed ID: 15466109
    [No Abstract]   [Full Text] [Related]  

  • 9. Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.
    Hiransuthikul N; Hiransuthikul P; Nelson KE; Jirawisit M; Paewplot R; Kasak S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1208-15. PubMed ID: 16438147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving screening and chemoprophylaxis among child contacts in India's RNTCP: a pilot study.
    Rekha B; Jagarajamma K; Chandrasekaran V; Wares F; Sivanandham R; Swaminathan S
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):163-8. PubMed ID: 23317950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to the implementation of isoniazid preventive therapy for tuberculosis in children in endemic settings: A review.
    Grace SG
    J Paediatr Child Health; 2019 Mar; 55(3):278-284. PubMed ID: 30604557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings].
    Yoshiyama T
    Kekkaku; 2000 Nov; 75(11):629-41. PubMed ID: 11140086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
    Apers L; Lynen L; Worodria W; Colebunders R
    Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erring on the side of action: time for HIV programmes to implement isoniazid preventive therapy.
    Granich R; Getahun H; Reid A; Raviglione M; De Cock KM
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):925-6. PubMed ID: 19723370
    [No Abstract]   [Full Text] [Related]  

  • 15. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
    Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of infection with Mycobacterium tuberculosis in young children post-2015: an opportunity to close the policy-practice gap.
    Graham SM
    Expert Rev Respir Med; 2017 Jan; 11(1):41-49. PubMed ID: 27910720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of policy and practice on the effectiveness of contact screening for tuberculosis.
    MacIntyre CR; Plant AJ
    Prev Med; 1998; 27(6):830-7. PubMed ID: 9922065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the treatment of latent tuberculosis.
    Chaisson RE
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S176-81. PubMed ID: 11144550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
    Sterling TR; Brehm WT; Moore RD; Chaisson RE
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):248-54. PubMed ID: 10094327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.